OPINION
Published 10:42 IST, December 22nd 2023
Swiss pharma mega-deal has healthy prognosis
Roche’s shares fell by 22% between January and late November 2023 amid major late-stage trial setbacks and a decline in demand for Covid-19 related products.
Swiss flag | Image:
Unsplash
- Listen to this article
- 3 min read
Advertisement
17:27 IST, December 19th 2023